Trial Profile
Phase I study in the continual administration of BK-UM against HB-EGF [heparin binding EGF-like growth factor] for patients with advanced or recurrent ovarian cancer
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 07 May 2008
Price :
$35
*
At a glance
- Drugs CRM 197 (Primary)
- Indications Ovarian cancer
- Focus Adverse reactions
- 07 May 2008 New trial record.